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Abstract
A central issue of myogenesis is the acquisition of identity by individual muscles. In Drosophila, at the time muscle
progenitors are singled out, they already express unique combinations of muscle identity genes. This muscle code results
from the integration of positional and temporal signalling inputs. Here we identify, by means of loss-of-function and ectopic
expression approaches, the Iroquois Complex homeobox genes araucan and caupolican as novel muscle identity genes that
confer lateral transverse muscle identity. The acquisition of this fate requires that Araucan/Caupolican repress other muscle
identity genes such as slouch and vestigial. In addition, we show that Caupolican-dependent slouch expression depends on
the activation state of the Ras/Mitogen Activated Protein Kinase cascade. This provides a comprehensive insight into the
way Iroquois genes integrate in muscle progenitors, signalling inputs that modulate gene expression and protein activity.
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Introduction
In Drosophila as in vertebrates the proper function of the
muscular system relies on the generation of a stereotyped pattern
of discrete muscles and their intimate connection with the nervous
system, which together control the adequate release of contraction
power to fulfil the functional requirements of the organism. The
formation of a muscle pattern is therefore of great importance and
consequently many efforts have been devoted to solve the central
problem of the acquisition of muscle identity. The embryonic
Drosophila muscle pattern comprises thirty elements in each
abdominal hemisegment (Figure 1G). Each muscle is a syncytial
fibre whose unique characteristics, i.e., position, size, attachment
to tendon cells, innervation and pattern of gene expression allow
its unambiguous identification [1,2]. Muscle specification is a
stepwise process that ensures the local singling out of a population
of myoblasts, the founder myoblasts, each of them containing the
necessary information to give rise to a unique muscle. The origin
of founder myoblasts can be traced to late embryonic stage 10
when groups of mesodermal cells (the promuscular clusters) start
expressing the proneural gene lethal of scute and acquire myogenic
competence [3]. Opposing activities of Notch and Receptor
Tyrosine Kinase signalling pathways ensure that only one cell in
the cluster will segregate as a muscle progenitor [4]. This will
divide asymmetrically to generate two sibling founder myoblasts or
a founder myoblast and an adult muscle precursor [3,5,6]. The
unselected cells of the promuscular clusters, by activation of the
Notch signalling pathway, will initiate the expression of the
transcriptional regulator Myoblasts incompetent (also called
Gleeful and Lame duck) and become fusion competent myoblasts
that by fusing to founders will give rise to multinucleated fibres
[7–9]. Regarding muscle identity, each progenitor and founder
exhibits a specific code of gene expression that confers to muscles
their unique characteristics. The components of these codes are
accordingly named muscle identity genes (reviewed in [2,10,11]).
The identity code is transmitted to all the nuclei in the syncytium
through the process of myoblast fusion [12]. According to their
patterns of expression muscle identity genes can be grouped into
three categories. Type I includes genes expressed by progenitors
and whose expression is maintained in sibling founders and
muscles. Examples are apterous, ladybird (lb) and Pox meso (Poxm)
[13–15]. Type II identity genes are expressed in progenitors but
differentially regulated in sibling founders, being lost from one of
them and the corresponding muscles. Examples are Kru¨ppel (Kr),
even-skipped (eve), collier and slouch (slou) [3,4,16–18]. And finally type
III refers to genes expressed by progenitors and founders of
muscles sharing common characteristics. vestigial (vg), expressed by
all internal muscles, is the only known member of this class
[12,19]. Regarding the onset of their expression a few muscle
identity genes, such as Kr, eve and collier, are already expressed in
the promuscular cluster, before the segregation of muscle
progenitors [4,16,18,20] whereas other genes, like Connectin (Con),
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initiate their expression in already segregated progenitors
[4,16,18,20].
In this study we identify araucan (ara) and caupolican (caup), two
members of the Iroquois gene complex (Iro-C), as novel type III
muscle identity genes. The Iro-C genes encode homeoproteins
conserved throughout the animal kingdom. They are organized in
genomic clusters of three paralogous genes, one in the case of
Drosophila and usually two in most vertebrates [21]. They
participate in a wide variety of developmental processes, mainly
related to the specification and patterning of diverse territories of
the body, including the lateral mesonotum and dorsal cephalic
region of Drosophila, the neural ectoderm of Xenopus and cranial
placode derivatives of zebrafish [22–30]. Here we show by means
of genetic approaches that ara and caup function redundantly in the
specification of the lateral transverse (LT) muscles, since in the
absence of both genes LT1–4 muscles loose their LT fates and
acquire those of other muscles.
At present there is compelling evidence that muscle progenitors
can integrate positional and temporal signalling inputs. This
promotes the expression of unique combinations of muscle identity
genes, which confers on them their ultimate fate [14–18,31,32].
There has been extensive analysis on the regulation of some of
these genes, such as eve and collier [4,33,34], which has allowed to
propose candidate cis-regulatory modules for founder muscle
specific expression [35]. However, very little is known about how
progenitors integrate the activity of the transcription factors
encoded by these genes, about the identity of their direct targets
(save in the cases of Kr and Lb [36–38]), and of their hierarchical
relationships and their putative post-transcriptional regulation. In
this report we have focused on these issues in relation to the
function of the ara/caup identity genes. We demonstrate that the
implementation of the lateral transverse muscle fate requires the
repression mediated by Ara/Caup of the muscle identity genes slou
and vg, to avoid reiteration of other muscle fates regulated by these
transcription factors. In addition, we identify slou as a potential
direct target of Ara/Caup. Furthermore, our tissue culture and in
vivo experiments show that the repression of slou by Ara/Caup in
LT precursors requires the activity of the Ras/Mitogen Activated
Protein Kinase (Ras/MAPK) pathway to be kept at a very low
level, since otherwise Caup is converted from a repressor to an
activator of slou. This is to our knowledge the first evidence of the
interplay between the Receptor Tyrosine Kinase signalling
pathways and the activity of a muscle identity transcription factor.
Therefore, during Drosophila embryogenesis, and for the acquisi-
tion of the lateral transverse muscle fate, the homeoproteins Ara
and Caup appear to act at a nodal point in muscle progenitors, as
they integrate positional and temporal signalling inputs that
modulate their activity on subordinate identity genes.
Results
Expression of Iro-C genes during muscle development
The patterns of expression of ara and caup in the embryonic
ectoderm have been previously reported [39,40]. In this work we
focus on the embryonic ara and caup mesodermal expression. In
situ hybridization showed that here both genes were similarly
expressed (Figure 1 and results not shown). At early stage 11 caup
(and ara) transcripts and proteins are detected in groups of cells of
the presumptive visceral trunk mesoderm (Figure 1A-1A90, the
available anti-Caup antibody recognises both Ara and Caup
proteins). By mid stage 11 they are expressed at the same dorso-
ventral level in the visceral mesoderm and in the dorsolateral
ectoderm (Figure 1B-1B90). Expression in the visceral mesoderm
declined at late stage 11 when it became detectable in groups of
cells of the somatic mesoderm (promuscular clusters [3], Figure 1C
and 1C9), from where a subset of muscle progenitors (P) still
expressing ara/caup, will segregate slightly later (stage 12,
Figure 1D). Expression was maintained in sibling founder
myoblasts (Fs in Figure 1D9) derived from ara-caup-expressing
progenitors and in the muscles they give rise to (Figure 1E-1E0),
namely LT1–4, dorsal transverse 1 (DT1) and segment border
muscle (SBM) (Figure 1F and 1G). The expression in the somatic
mesoderm of the third member of the Iroquois complex, mirror
[41] did not overlap with that of ara-caup (not shown).
The early expression of ara/caup in all lateral muscles with
vertical orientation, suggested a possible role as muscle identity
genes. Therefore, we compared their expression with that of
several muscle identity genes. For the LT1–4 muscles, ara/caup
were co-expressed with Kr in the promuscular clusters from which
progenitors PLT1/LT2 and PLT3/LT4 are singled out (Figure 2A).
ara/caup expression was maintained at high levels in both
progenitors that also express Kr (Figure 2B). Whereas Kr expression
decayed in founders LT1 and LT3 before the onset of myoblast
fusion and in LT2 and LT4 muscles from stage 15 onwards [18],
expression of ara/caup was maintained in the four founders
(Figure 2D and 2E). These also expressed Con, co-expression that
was maintained in the mature LT1–4 muscles (Figure 1G). In the
case of muscle DT1, the onset of ara/caup expression coincided
with that of Con and slou in the progenitor of DT1 and dorsal
oblique 3 (DO3) muscles (Figure 2C) and it appeared to be
maintained in DT1 founder (Figure 2E) and mature muscle at low
levels (Figure 1G). Finally, ara/caup co-expressed with lb in the
SBM founder (Figure 2D), but were not be detected in the lb-
expressing progenitor and promuscular cluster. In summary,
different muscle lineages expressed ara/caup at different steps of the
myogenic programme (Figure 2F). In the LT1–4 case ara/caup and
Kr were detected at the earliest lineage stage, that is in promuscular
clusters, preceding Con expression in progenitors (not shown); in
the DT1/DO3 lineage ara/caup and slou were first detected in the
already singled out DT1/DO3 progenitor and in the SBM ara/
caup expression was first detected in the SBM founder after lb
expression.
Author Summary
In Drosophila, as in vertebrates, the muscular system
consists of different types of muscles that must act in
coordination with the nervous system to control the
adequate release of contraction power required for the
proper functioning of the organism. Therefore, the
acquisition of specific identities by individual muscles is a
key step in the generation of the muscular system. In
Drosophila, muscle progenitors (specific myoblasts that
seed the formation of mature muscles) integrate positional
and temporal signalling inputs, resulting in the expression
of unique combinations of muscle identity genes, which
confer on them specific fates. Up to now, very little was
known of how this integration takes place at a molecular
level and how a particular code is translated into a specific
muscle fate. Here we show that the acquisition of the
lateral transverse muscle fate requires the repression
mediated by Araucan and Caupolican, two homeoproteins
of the Iroquois Complex, of other muscle identity genes,
like slouch and vestigial. The repressor or activator function
of the Iroquois proteins depends on the activity of the Ras
signalling pathway. Therefore, our work places Iroquois
genes at a nodal point that integrates signalling inputs
and regulates protein activity and cell fate determination.
Ara/Caup Regulate LT Muscle Identity
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Ara and Caup are required for specification of lateral
transverse muscles
During imaginal development Ara and Caup can functionally
substitute each other in all territories where their function has been
investigated [22,23,28]. Thus, to analyse their role in embryonic
myogenesis and evaluate the possible contribution of mirror to any
phenotype we might find, we used three deficiencies: Df(3L)iroDFM3,
which removes both ara and caup, (and probably affects mirror
regulation, [23,28]), Df(3L)iroEGP6, which removes ara and caup
without affecting mirror and its regulatory region, and Df(3L)iroEGP5,
which only removes mirror [42]. Whereas Df(3L)iroEGP5 embryos did
not show any detectable phenotype in the lateral region (not shown),
a distortion of the lateral larval muscle pattern (visualised
with antibody MAC141 to Tropomyosin) was found in both
Df(3L)iroDFM3 and Df(3L)iroEGP6 embryos (Figure 3A–3C). In more
than 95% of cases muscles with LT morphology were absent
(Figure 3E). Instead, some fibres with abnormal orientation
appeared in the lateral and ventral regions, but never inserted at
the LT attachment sites (asterisks in Figure 3B and 3C). The loss of
LT muscles was further verified by loss of expression of the specific
LT muscle marker CG13424, recently renamed lateral muscles scarcer
(lms) [43] at stage 15 and the absence of Con expression in the lateral
somatic mesoderm (Figure S1). Both DT1 and SBM fibres
developed with normal morphologies (Figure 3A–3C and Figure
S1). To examine the individual contribution of ara and caup to the
phenotype we resorted to embryos mutant for only one of these
genes (ara in ararF209, [28], or caup in iroEGPD1, [42]). The larval
muscle pattern was normal in both mutants (not shown). Thus,
similarly to imaginal development, ara and caup appear to play
redundant roles during embryonic myogenesis.
The absence of muscles with LT morphology in ara/caup mutants
could be due to a failure of otherwise well specified muscles to find
the right insertion to tendon cells, due to ectodermal requirement of
Iro-C genes, or to a misspecification of the muscles. Two
independent results indicated that Iro-C genes are required
autonomously in the mesoderm to specify the LT fate. First, the
Figure 1. Pattern of expression of ara and caup during myogenesis. Wild type embryos of the indicated developmental stages were
hybridized with caup (A, A9, B, B9, C, E, E9) or ara (F) riboprobes or sectioned after anti-Caup antibody staining (A0, A90, B0, B90, C9, D, D9, E0). (A-A90) caup
is expressed in the visceral mesoderm at early stage 11 (arrowheads, A and A9 show the same embryo with different focus as shown in the inset). (B-
B90) At mid stage 11 caup is expressed in the visceral mesoderm (arrowheads) and in the lateral ectoderm (arrows). Asterisks in A and B point to the
primordium of the proventriculus. A90, B90 close-ups of the images shown in A0 and B0, respectively. (C-C9) Early stage 12/late stage 11 embryos. (C)
caup is expressed in the lateral ectoderm (arrowhead) and in groups of mesodermal cells (arrow). (C9) Cross-section showing caup expression in
ectodermal cells (Ec), visceral mesoderm (Vms) and promuscular clusters (Cl). (D, D9) At stage 12 caup is expressed in individual muscle progenitors (P
in D) and slightly later in both founders (Fs) derived from the division of progenitors (D9). (E-E0) At stage 13 Caup is detected in a lateral stripe of
ectodermal cells (arrowheads in E, E9, Ec in E0) and in muscle precursors (arrows in E, E9, M in E0). (F) Stage 15 embryo showing expression of ara in the
ectoderm and in mature muscles. (G) Stage 15 embryos doubled stained with anti-Caup (green) and antibodies against Con, Slou or Ladybird (red).
caup is co-expressed with Con in LT1–4 muscles, with slou in DT1 and with lb in SBM. The drawing scheme summarises the wild type patterns of
expression of caup (green), slou (red), lb (yellow) and Con (black contour line) in relation to the wild type complement of abdominal muscles. For
muscle nomenclature see [1].
doi:10.1371/journal.pgen.1002186.g001
Ara/Caup Regulate LT Muscle Identity
PLoS Genetics | www.plosgenetics.org 3 July 2011 | Volume 7 | Issue 7 | e1002186
Figure 2. Onset of Caup expression in muscles in relation to other muscle identity genes. All images show a detail of an embryonic wild-
type abdominal hemisegment stained with antibodies against Caup (green) and different muscle identity proteins. Images show a ventral view of the
embryo, with the exception of B and C that correspond to lateral views. (A–C) Stage 11 embryos. (A) caup and Kr (red) are co-expressed in a lateral
transverse promuscular cluster (CLTS). (B–C) caup is co-expressed with Kr (blue) in progenitors of LT muscles (PLT1/LT2 and PLT3/LT4, B) and with slou/S59
(red) in DT1/DO3 progenitor (PDT1/DO3, C). (D) Late stage 12 embryo co-expressing caup and lb in the SBM founder (FSBM). (E) Stage 12 embryo
showing co-expression of caup with slou/S59 (red) in DT1 founder (FDT1) and with Kr (blue) in LTs founders (FLT1–4). The position of LL1, LL1sib and
VA1–3 founders (FLL1, FLL1sib, FVA1–3) and the ventral adult muscle precursor are also indicated. (F) Schematic representation of ara/caup expression in
the LTs, DT1 and SBM lineages (SBM lineage as revised in [17]). LaPs, lateral adult muscle precursors; PC, promuscular cluster; P, muscle progenitor; Fs,
founder myoblasts.
doi:10.1371/journal.pgen.1002186.g002
Figure 3. Muscle phenotypes of Iro-C mutant embryos. (A–D) Latero-ventral region of stage 16 wild-type (A), Df(3L)iroDFM3 (B), Df(3L)iroEGP6 (C)
and stage 15 Df(3L)iroDFM3 mef-2GAL4::UAS-ara (D) embryos stained with anti- Tropomyosin antibody (green). The position of ventral wild-type LT
muscle tips and LT attachment sites are marked with arrowheads and brackets, respectively. Note the absence of muscles with LT morphology and
insertions at LT attachment sites, and the presence of morphologically normal DT1 and SBM muscles (arrows) in the mutant backgrounds (B, C).
Asterisks indicate morphological abnormal latero-ventral muscles in these embryos. This phenotype is rescued by mesodermal ara expression with
the pan-mesodermal driver mef2-GAL4 (D). (E) Quantification of phenotypes produced by the loss of ara/caup in LT muscles. * Refers to changes in
shape, orientation or attachment sites; n, numbers of hemisegments analysed (stages 14–16); -, not determined.
doi:10.1371/journal.pgen.1002186.g003
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normal development of LT muscles in Df(2L)5 embryos devoid of
Iro-C gene expression at the ectoderm (Figure S2 and [44]). And
second, the rescue of the muscle phenotype of Df(3L)iroDFM3
embryos by Ara supplied exclusively in the mesoderm (using
myocyte enhancer factor 2 (mef2)-GAL4 as driver, Figure 3D).
All progenitors and founders segregate in Df(3L)iroEGP6
mutant embryos
We next examined whether the loss of LT muscles was due to
either a failure in the segregation of muscle progenitors (absences
and/or duplications) or to an early transformation of the fate of LT
progenitors. To discern between these possibilities we combined the
reporter line rP298, which expresses ß-galactosidase in all
progenitors and founders [32,45] with Df(3L)iroEGP6. We focussed
on the previously well-established muscle lineages labelled by Slou/
S59 [3,17] and the LT1–4 lineages labelled by Kr [18]. With these
markers in the lateral-ventral region of rP298 embryos we can
identify the following founders (Figure 4A-4A0 and insets below). In
the dorsalmost lateral mesoderm we find the sibling founders DT1
and DO3 (expressing slou) and the lateral longitudinal 1 (LL1)
founder and its sibling (expressing Kr). Immediately below segregate
the four LT founders (expressing Kr). And more ventrally appear the
sibling ventral acute 1 (VA1) and VA2 founders (which express Kr
and slou) and the VA3 founder and its sibling, the ventral adult
precursor (that express slou). In Df(3L)iroEGP6 embryos we observed
the same number of identifiable founders (Figure 4B and 4B9).
There were however significant differences in terms of patterns of
gene expression. Namely, the presumptive LT3–4 founders now
expressed slou in addition to Kr (Figure 4B and 4B9 and insets below).
This code of muscle identity gene expression is similar to that of
VA1 and VA2 founders (Figure 5A), suggesting an early
transformation of LT3–4 to VA1–2 muscles.
Ara and Caup implement LT muscle fate by repression of
muscle identity genes in progenitors
The absence of all muscles with LT morphology in ara/caup
mutant embryos prompted us to examine whether, in addition to
the putative transformation of LT3–4 towards VA1–2, there was a
similar change of fate for LT1–2. LT progenitors express Kr, caup,
Con and lms, PLL1/LL1sib expresses Kr and vg, and PVA1/2 Kr, slou,
Con and Poxm (Figure 5A and 5B). Using a combination of these
markers we found in the lateral region of Df(3L)iroDFM3 embryos
an ectopic muscle that expressed Kr+Vg, the code of LL1 (LL1*,
Figure 5C) and an ectopic muscle VA2 (VA2* in Figure 5E–5G).
This change of muscle identity could take place in founders or at
the progenitor state. If this were the case, we anticipated that both
muscles resulting from sibling founder myoblasts should be
duplicated in Df(3L)iroDFM3 embryos. Indeed, using anti-Poxm,
which labels VA1–3 ([14] and Figure 5B), and antibodies to Kr
and Slou, which are maintained only in VA2 (Figure 5B and 5D),
we identified two VA2 muscles (that co-express Poxm and Kr) and
two Poxm-expressing VA1 muscles in late stage 14 Df(3L)iroDFM3
embryos (Figure 5F). The presence of the duplicated VA1 and
VA2 muscles was more evident at stage 15 when Poxm was only
weakly expressed in VA2 muscles (Figure 5G). We concluded that
Ara and Caup were required to specify LT progenitors and that
implementation of this fate implies the repression of specific
muscle identity genes, such as slou in PLT3/4 and vg in PLT1/2.
Moreover, it seemed that the only muscles affected by the lack of
ara/caup were those in which these genes were already expressed in
the corresponding promuscular clusters, since the fate of DT1 and
SBM, visualised by the expression of slou, Con and lb, was
apparently unaffected in Df(3L)iroDFM3 embryos (Figure 2F,
Figure 5D and 5E, and Figure S1E–S1H).
Ras/MAPK cascade modulates the regulation of slou by
Caup in Schneider-2 cells
Our data suggested that Ara/Caup might act as repressors of
slou in the Drosophila mesoderm. Therefore we decided to
investigate whether slou might be a direct target of Ara/Caup.
Figure 4. Changes of fate in LT founders of Iro-C mutant
embryos. (A-B9) Late stage 12 control (A-A0) and rP298;;Df(3L)iroEGP6
sibling embryos (B, B9) stained with anti-ßgal (red), anti-Slou/S59 (green)
and anti-Kr (blue) antibodies. ßgal staining is used as a marker for
founders (rP298 line) and the white rectangle in A marks the individual
segment shown in A9, A0. (A9, B) Drawings indicating the relative
position of the founders visualised in the corresponding (A0, B9)
confocal images. The founders expressing Kr or slou/S59 are labelled by
their muscle’s acronyms. Note that although founder segregation is
unaffected in Df(3L)iroEGP6 embryos, the specification of LT founders is
altered (B, B9). Thus, two of the LT founders (LT3–4* in B, B9), marked by
expression of Kr, also express slou/S59, a property exclusive of the VA1–
2 founders (see insets below for details of LT founders, the asterisks
mark VT1 founder, that expresses slou/S59 but not Kr. Note that Kr is
disappearing from LT1 and 3). All panels show Z projections of several
consecutive confocal sections with the exception of A0 that corre-
sponds to a combination of two Z projections, one lateral, as the one
shown in B9, and other rotated ventrally to show VAs founders. For
muscle nomenclature other than ventral adult precursor (VaP) see [1].
doi:10.1371/journal.pgen.1002186.g004
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An ‘‘in silico’’ search of a previously reported slou cis-regulatory
region [46] identified two putative Iro binding sites (BS) at
positions +129 (BS1) and 21642 (BS2), relative to the transcription
start site, which match the consensus ACAN2–8TGT ([47] and
Figure 6A). We cloned this regulatory region in a Luciferase
reporter vector and measured Luciferase activity in Drosophila
Schneider-2 (S2) cells transiently transfected with this construct
and increasing amounts of HA-tagged Caup. Contrary to
expectations, we found that addition of Caup-HA increased the
basal Luciferase activity driven by the slou regulatory region in a
dose dependent manner (blue bars in Figure 6B), indicating that
Caup acts as a transcriptional activator of slou under these
conditions. The reported regulation of the chicken Irx2 factor by
MAPK (that switches it from repressor to activator) could explain
this result [48]. Since Western Blot analysis of S2 lysates using an
antibody against diphospho-extracellular-signal related kinase
(dpErk) showed the MAPK pathway to be active in S2 cells
(Figure 6C) and we have obtained experimental evidence showing
the presence of phosphorylated Caup in S2 cells with constitutively
active MAPK pathway (N.B, A.S.T and S.C, manuscript in
preparation), we hypothesized that the activation effect of Caup in
S2 cells could be due to the Ras/MAPK cascade turning Caup
from transcriptional repressor into activator. Indeed, the inhibition
of the Ras/MAPK pathway by the PD98059 MAP-erk kinase-1
(MEK1) inhibitor induced a Caup-dose dependent decrease in
Luciferase activity driven by the slou regulatory sequences
(Figure 6B, red bars). This result could not be attributed to a
direct effect of the inhibitor over the slou promoter, since its
addition did not modify the basal Luciferase activity of the
construct (Figure 6B).
To test whether Caup-dependent transcriptional regulation
relied on a direct interaction of Caup with the slou regulatory
region we performed electrophoretic mobility shift assays (EMSA)
with in vitro translated Caup and wild-type and mutated Caup-
BS. These assays indicate efficient binding of Caup to BS1, which
is abolished by BS1 mutation and deletion (Figure 6D). In contrast,
Caup appears not to bind BS2 under these experimental
conditions (not shown).
Next we examined the functional relevance of BS1 and BS2 in
the Luciferase reporter assay. Deletion of BS2 had no major effect
on Caup-dependent luciferase expression compared to the wild-type
promoter (Figure 6E and 6F compare with Figure 6B). This result
suggested that Caup does not bind to BS2 (as indicated by the
EMSA data). Unexpectedly, deletion of BS1 resulted in a more
efficient activation of luciferase expression than that driven by the
wild type regulatory region (Figure 6E). This suggested that
binding of Caup to BS1 somehow impaired transcription. Note
that the activation of luciferase driven by the BS1 mutated
regulatory region was still dependent on the MAPK pathway
(Figure 6E and 6F). This suggests that such activation appears to
Figure 5. Muscle fate transformations in Df(3L)iroDFM3 embryos. (A) Summary of identity codes for promuscular clusters (Cl), progenitors (P)
and muscles missing or duplicated in ara/caup mutants, indicated by a colour code. (B) Schematic drawings of the body wall muscles in wild type
abdominal hemisegments, depicting the muscles that express the marker indicated on top. (C) Stage 14 Df(3L)iroDFM3 embryo showing a duplication
of LL1 fate in the lateral region, pointed by an arrow (LL1*). As shown in the corresponding schemes, LL1 is the only muscle that co-expresses Kr
(green) and vg (red) in the lateral region. (D, E) Double-staining with anti-Kr (green) and anti-Slou/S59 (red) antibodies in stage 14 wild-type (D) and
Df(3L)iroDFM3 (E) embryos, showing duplication of VA2 fate in the mutant embryo that co-expresses Kr and slou/S59 (VA2*). (F) At stage 14 two VA2-
like muscle precursors expressing Kr and Poxm and two Poxm-expressing VA1-like precursors are observed in Df(3L)iroDFM3 embryos. (G) The
duplicated muscles are clearly visualised at stage 15, when Poxm expression is still clear in VA1 but fading in VA2 muscles. Note the presence of two
muscles expressing higher levels of Poxm (green, VA1 and VA1*) next to two fibres co-expressing low levels of Poxm and slou/S59 (red) in a
Df(3L)iroDFM3 embryo.
doi:10.1371/journal.pgen.1002186.g005
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depend on the binding of a MAPK-dependent phosphorylated
protein, which we hypothesize might be Caup, to a so far
unidentified binding site. Thus, the analysis in S2 cells confirmed
the relevance of BS1, but not of BS2 on Caup-dependent
regulation.
Additionally, we have analysed the evolutionary conservation of
these putative Caup-BS among several Drosophila species (Figure
S3). Notably, BS1 is located in a highly conserved region and its
sequence is identical across the melanogaster group, whereas
neither BS2 nor the adjacent sequences are conserved. These data
further reinforce the relevance of BS1 for Caup-dependent slou
regulation.
Our results are thus consistent with a direct effect of Caup on
slou regulation. However, it cannot be ruled out the possibility of
the existence in vivo of a transcription factor, acting downstream
of ara/caup, that could repress slou through BS1 or through a still
unidentified regulatory sequence of slou.
Caup integrates in vivo inputs from the Ras/MAPK
cascade for its regulation of slou
To further examine in vivo the regulatory activity of Caup on
slou (Figure 7B, 7C), we ectopically expressed caup or ara in VA1–3
using Con-GAL4 and checked whether they would repress slou in
the VA2 muscle. This was indeed the case (Figure 7B, 7D, 7F-7F0
and not shown). Loss of slou expression caused by ectopic caup
reproduced the morphological defects in VA2 previously described
in slou mutants (Figure 7F-7F0 and [17]). To analyse whether the
morphological effect of Caup on muscle VA2 development was
only due to Caup-dependent repression of slou, we forced the
expression of both genes using the Con-GAL4 driver. In this
experimental condition Caup was unable to repress UAS-slou
expression and the VA2 muscle and its morphology seemed
unaffected (Figure 7F-7G0).
Once verified the repressor activity of Caup on slou during
myogenesis, to analyse the regulatory potential of BS1 in vivo we
generated transgenic flies harbouring the wild-type or the BS1
deleted version of the slou regulatory region. The wild-type
regulatory region only partially reproduced the slou endogenous
expression, as it drove lacZ expression in the CNS but not in the
muscles (not shown and Figure S4). In contrast, the construct
lacking BS1 behaved congruently with our S2 cells results, since it
drove ectopic expression of lacZ in the lateral muscles (Figure S4).
Curiously, up-regulation of lacZ was found in the 4 lateral muscles
and not only in the ones that show slou expression in the absence of
Ara/Caup (Figure 4B). Thus we interpret that this construct, while
missing some of the regulatory sequences required for slou
mesodermal expression, it contains those required for Caup
mediated repression in the mesoderm. In addition, the absence of
Figure 6. Direct interaction of Caup with slou regulatory region and its modulation by the Ras/MAPK pathway. (A) Diagram of the 2 Kb
long slou promoter region (from 21828 to +153 nt) used to drive Luciferase expression. This fragment contains two putative binding sites for Ara/
Caup, BS1 and BS2. (B) Effect of increasing amounts of Caup-HA on the Luciferase activity driven by slou promoter in the absence (blue bars) and
presence (red bars) of PD98059 MEK1 inhibitor. (C) Representative western blots of lysates of S2 cells expressing increasing amounts of Caup (upper
panel) in the absence and presence of PD98059, showing the state of activation of the Ras/MAPK cascade (middle panel) and Tubulin expression as
loading control (lower panel). (D–F) Mutagenesis analysis of slou regulatory region. (D) Binding of Caup to the indicated slou regulatory fragments,
containing BS1 determined by EMSA. Binding of Caup to wild-type fragment resulted in the formation of complexes with reduced mobility (asterisk in
lane 4), which was more evident in the presence of increased amounts of Caup (asterisk in lane 7). No shift was observed when fragments devoid of
BS1 (D BS1, lanes 5, 8) or point-mutated (Mut BS1, lanes 6, 9) were used or in the absence of Caup (lanes 1–3). (E, F) Effect of Caup-HA (1 mg) on the
Luciferase activity driven by wt and mutated (BS1*, BS2*) slou promoter regions in the absence (E) and presence (F) of PD98059 inhibitor. Statistical
analyses for Luciferase assays were performed using the paired two-tailed Student’s t-test. The data are presented as means 6 S.E.M. of 3
independent experiments. *P,0.05, **P,0.001 compared to basal (B) or wt (E, F) conditions.
doi:10.1371/journal.pgen.1002186.g006
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strict correlation between the phenotypes of deletion of BS1 and
lack of Ara/Caup, might indicate the ability of other transcription
factor(s) to regulate slou expression in LT1–2 through BS1.
To investigate whether the effect of the MAPK cascade on the
transcriptional activity of Ara/Caup found in the S2 cell assay is
also at work during myogenesis we examined whether there is a
correlation between MAPK signalling and Caup transcriptional
regulatory activity. We looked at the state of activation of this
pathway in the LT promuscular cluster, where Ara/Caup repress
slou, and found that it did not appreciably express dpErk
(Figure 7H). Therefore, a repressor activity of Ara/Caup
correlates in vivo with the absence of MAPK signalling. Next,
we tested whether forced activation of the MAPK pathway in the
mesoderm could interfere with the repressor activity of endoge-
nous Caup in LT promuscular clusters. This was indeed the case,
since activation of the MAPK pathway using twist-GAL4; 24B-
GAL4 to drive the activated form of Ras85D (rasV12 [49]) allowed
co-expression of caup and slou in this cluster (Figure 7I). Similarly,
Figure 7. Ras/MAPK modulates the transcriptional activity of Caup on slou during myogenesis. (A) Schematic drawing of muscles
expressing Con in abdominal hemisegments. (B–E) Lateral views of abdominal hemisegments of stage 15–16 wild type (B), Df(3L)iroDFM3 (C), Con-
GAL4::UAS-caupHA (D) and Con-GAL4::UAS-caupHA; UAS-rasV12 (E) embryos, stained with S59 antibody. Note the presence of an ectopic VA2 muscle
(VA2*) in Df(3L)iroDFM3 (C), the absence of slou in VA2 when caup is ectopically expressed in this muscle (arrow, D, see also F-F0), and the failure of
Caup to repress slou/S59 in VA2 muscle in the presence of the activated form of Ras, rasV12 (E). (F-G0) Lateral views of stage 15–16 Con-GAL4::UAS-
caupHA; UAS-GFP (F-F0) and Con-GAL4::UAS-caupHA; UAS-slou (G-G0) embryos stained with the indicated antibodies. Note that co-expression of caup
and slou in VA2 does not appreciably modify the morphology of the muscle (arrows in G-G0). As an internal control co-expression of UAS-caup and
UAS-GFP still repressed endogenous slou and prevented the VA2 fate (F-F0). (H) Close-up of a lateral transverse promuscular cluster (outlined) in a
stage 11 wild-type embryo showing co-expression of Caup (red) and Kr (blue) in all cells of the clusters. Note that the activation of the Ras/MAPK
cascade (dpErk, green) only takes place at low levels in the segregating progenitor (yellow arrowhead) but not in the rest of the cluster. (I) Close-up of
LT cluster in twist-GAL4; 24B-GAL4::UAS- rasV12 stage 11 embryo. Early activation of the Ras/MAPK pathway prevents the repression of slou by Caup in
the LT cluster. (J) Close-up of the dorsal mesoderm of a mef2-GAL4::UAS-ara stage 15 embryo showing ectopic expression of slou in eve-expressing
muscles.
doi:10.1371/journal.pgen.1002186.g007
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late co-expression of rasV12 and caup (Con-Gal4 driver) blocked the
repression activity of Caup on slou (Figure 7D and 7E). Finally, to
test whether MAPK signalling not only prevented Caup-
dependent repression of slou but also converted Caup from
repressor to activator, we looked at the expression of slou after
early pan-mesodermal Caup expression (mef2-GAL4). As shown in
Figure 7J, Ara was indeed able to ectopically activate slou in
Drosophila epidermal growth factor receptor (DER)-dependent eve-
expressing muscles.
Discussion
The study of myogenesis in Drosophila has increased the
understanding of how the mechanisms that underlie the
acquisition of specific properties by individual muscles are
integrated within the myogenic terminal differentiation pathway.
Thus, the current hypothesis proposes that distinct combinations
of regulatory inputs leads to the activation of specific sets of muscle
identity genes in progenitors that regulate the expression of a
battery of downstream target genes responsible for executing the
different developmental programmes (reviewed in [2,10,38]).
However, the analysis of the specific role of individual muscle
identity genes and of their hierarchical relationships is far from
complete since the characterisation of direct targets for these
transcriptional regulators is very scarce [36,37].
Here, we report the identification of ara and caup, two members of
the Iroquois complex, as novel type III muscle identity genes. We
find that the homeodomain-containing Ara and Caup proteins are
necessary for the specification of the LT fate. ara/caup appear to be
bona fide muscle identity genes. Indeed, similarly to the identity
genes Kr and slou [17,18], absence of ara/caup does not interfere with
the segregation of muscle progenitors or their terminal differenti-
ation, but modifies the specific characteristics of LT1–4 muscles,
which are transformed towards VA1, VA2, LL1 and LL1 sib fates.
These transformations may be due in part to the up-regulation of
slou and vg in the corresponding muscles. Thus, a recent report [50]
shows that forced expression of vg in LT muscles induces changes in
muscle attachments similar to the ones observed in LT1 in ara/caup
mutant embryos. However, it should be stressed that although in
ara/caup mutants LT muscles are lost in more than 95% of cases,
they are not completely transformed into perfect duplicates of the
newly acquired fates. For instance, while the specific LT marker lms
is lost in 91% of cases, ectopic slou expression is detected in only 75%
of cases. These partial transformations might be due to differences
in the signalling inputs acting in the mesodermal region from where
these muscles segregate (see below). Our unpublished data also
showed that forced pan-mesodermal expression of ara/caup alter the
fates of many muscles both in dorsal and in ventral regions without
converting them into LT muscles (i.e., they do not ectopically
express lms). Similarly, Kr and slou ectopic expression is not sufficient
to implement a certain muscle fate [17,18]. The failure to recreate a
given muscle identity by adding just one of the relevant muscle
identity proteins reveals the importance that cell context, that is, the
specific combination of signalling inputs and gene regulators present
in each cell, have in determining a specific muscle identity.
Our analysis of the myogenic requirement of ara/caup has
revealed several features about how these genes act to implement
LT fates. Thus, although they are expressed in six developing
embryonic muscles, only four of them, LT1–4, are miss-specified
in the absence of Ara/Caup. The remaining two, DT1 and SBM,
seem to develop correctly, according to morphological as well as
molecular criteria. It is worth noting that the requirement for ara/
caup genes in these six muscles correlates with the onset of their
expression. Thus, in the affected LT1–4 muscles Ara/Caup can be
first detected at the earliest step of muscle lineages, that is in the
promuscular clusters. In contrast, in the unaffected muscles ara/
caup start to be expressed later, in the DT1/DO3 progenitor and
the SBM founder. This suggests that in muscle lineages ara/caup
have to be expressed very early to repress slou and vg to implement
the LT fate. Several data support this interpretation. For instance,
the observation that ara/caup are co-expressed with slou in DT1,
whereas they repress slou in LT3–4, may be related to the fact that
slou expression precedes that of ara/caup in the DT1 lineage.
Should this be so, one would expect that ectopic expression of ara
using the early driver mef2-GAL4, would repress slou in DT1, as it
actually does (Figure S5), whereas this repression is not evident
using the late driver Con-GAL4. Furthermore, the hypothesis of the
relevance of the timing of muscle identity gene expression for
muscle fate specification might also apply to the case of slou, where
a similar correlation between the strength of the loss-of-function
slou phenotypes in specific muscles and the onset of slou expression
has also been found [17].
It should be stressed that the generation of the LT code depends
not only on the early presence of Ara/Caup on the promuscular
clusters but also on the absence (or strong reduction) of DER/Ras
activity at that precise developmental stage and location (Figure 8).
There is a dynamic regulation of MAPK signalling in the lateral
mesoderm. Caup-expressing muscles develop from DER-indepen-
dent clusters whereas the duplicated muscles observed in ara/caup
mutants derive from progenitors that segregate very near the LT
progenitors [3], but originate in DER-dependent promuscular
clusters that are specified slightly later in development [4,51].
Furthermore we have observed both by in vivo and in cell culture
that low MAPK activity is required for Caup-dependent slou
repression. Therefore, we interpret the role of Ara/Caup in the
implementation of LT fate as follows (Figure 8). At mid stage 11 in
the myogenic mesoderm, groups of mesodermal cells acquire
myogenic competence as a result of interpreting a combinatorial
signalling code that reflects their position along the main body
axes, as well as the state of activation of different signalling
pathways [4]. Accordingly, these clusters initiate the expression of
lethal of scute and a unique code of muscle identity genes, as has
been shown in great detail for eve expression in the dorsal
mesoderm [34,35]. In the case of the dorso-lateral mesoderm this
code includes ara/caup and Kr and implements the LT fate. Since
the level of activation of the Ras/MAPK cascade is low in these
clusters, Ara/Caup will behave as transcriptional repressors,
preventing the activation of slou or vg in LT1–2 and LT3–4
clusters, which would be otherwise activated in this location. Thus,
Ara/Caup implement the LT fate by repressing the execution of
the alternative fates (Kr+, Slou+, Con+, Poxm+ and Kr+, Vg+)
that would give rise to duplicates of PVA1/VA2 and PLL1/LL1sib,
respectively, and by allowing a different identity gene code (Kr+,
Caup+, Con+, lms+) that generates the LT fate.
Slightly later the Ras/MAPK pathway becomes active at the
dorsolateral region (Figure 8). This changes the combinatorial
signalling code and coincides with a change in the muscle identity
genes expressed by the promuscular clusters that segregate from
this position, which now accumulate Kr but not Ara/Caup.
Progenitors born from them will express either slou or vg and give
rise to VA1–2 and LL1/LL1sib fates, all DER-dependent [51].
Our S2 cells experiments suggest a molecular mechanism by
which the Ras/MAPK pathway modulates the transcriptional
activity of Ara/Caup on slou. Thus, low MAPK activity and direct
binding of Caup to BS1 site of the slou gene would favour strong
repression of slou. BS1 could be embedded in a silencer regulatory
element or its binding to Caup may block transcription of the
downstream located luciferase gene. On the contrary, Caup-
Ara/Caup Regulate LT Muscle Identity
PLoS Genetics | www.plosgenetics.org 9 July 2011 | Volume 7 | Issue 7 | e1002186
dependent activation of slou would be dependent on MAPK
signalling. We hypothesize that MAPK–dependent Caup phos-
phorylation could modulate its interaction with different tran-
scriptional co-factors or/and its binding site affinity.
Furthermore, our in vivo evidence indicates a repressor function
of presumably non-phosphorylated Caup on slou since forced
activation of the Ras pathway allows co-expression of slou and caup.
On the other hand, the ectopic expression of slou induced by caup-
over-expression is suggestive of a possible activator function of
phosphorylated Caup.
The role of IRO proteins in cell fate specification is conserved in
both vertebrates and invertebrates (reviewed in [52]). Here we
have shown that the interplay between MAPK signalling and IRO
activity found in vertebrate neuroepithelium [48] is also at work in
Drosophila myogenesis. We have also identified a potential direct
target of Ara/Caup, slou and propose vg as a candidate gene to be
regulated by Ara/Caup. In both cases the genes subordinated to
ara/caup encode transcription factors that might in turn regulate
the expression of other genes, genes that must be repressed in LT
muscles in order to acquire the LT fate. These results, therefore,
provide insights into the way Ara/Caup control lateral muscle
identity and on the role of signalling pathway inputs to modulate
the activity of these transcription factors, with consequences in
their downstream targets. It also highlights the importance that the
specific combination of muscle identity genes, their hierarchical
relationships and their temporal activation have in determining
the identity of a given muscle cell, very alike to what is at work
during the acquisition of neural fates [53].
Materials and Methods
Drosophila stocks
The following stocks were used: Df(3L)iroDFM3, ararF209 [28],
Df(2L)5 [54], Df(3L)iroEGP6, Df(3L)iroEGP5, Df(3L)iroEGPD1 [42],
rP298 [32], mef2-GAL4 [55], Con-GAL4 [56], twist-GAL4; 24B-GAL-
4 (a gift from M. Baylies), UAS-ara, UAS-caup [28], UAS-caup-HA
(N. Barrios, unpublished) and UAS-rasV12 [49]. Ectopic expression
was generated by means of the GAL4/UAS system [57].
In situ hybridisation, immunohistochemistry, and
microscopy
Whole-mount in situ hybridisation with digoxygenin-labelled RNA
probes and immunocytochemistry were performed as described
previously [58]. Stained embryos were embedded in Araldite and
sectioned (3 mm) following standard procedures. The following
primary antibodies were used at the indicated dilutions: rat anti-
Caup (1:50) [23], guinea pig anti-Kr (1:500) [59], mouse anti-Lb (1:1)
[15], rabbit anti-Poxm (1:10) [14], rat and rabbit S59 (that recognises
Slou, 1:50) [3], rabbit anti-Alien (1:500) [60], mouse anti-Con (1:10)
[61], rabbit anti-Vg (1:500) [62], rat-anti- Tropomyosin (MAC141;
1:100; Babraham Tech), rabbit anti-Myosin (Myo; 1:300) [63], rat
anti-HA (1:1000; Roche); rabbit anti-ß-Gal (1:5000; Cappel) and
mouse anti- dpErk (1:50; Sigma). Images were obtained with confocal
microscopes MicroRadiance (BioRad) and LSM510META (Zeiss)
and analysed using the software Zeiss LSM Image or LaserSharp and
Adobe Photoshop 7.0. In most cases the figures correspond to z-
projections of series of confocal sections.
Cell culture and transfections
The 59-upstream region of slou (from 21828 to +153 nt) was
amplified via PCR and cloned in pGLHS43 vector, a modified
version of the pGL2-basic vector (Luciferase reporter plasmid,
Promega), obtained after substitution of the SV40 promoter by the
Drosophila heat-shock 43 minimal promoter (a gift from A. Baonza).
The putative Caup BS1 and BS2 were deleted using the ‘‘Quick
Change’’ site-directed mutagenesis kit (Stratagene, SantaClara,
CA). The sequences of the primers used to delete BS1 were 59-
GAGTTCTTAATCCAGCCGTGTTGTGTGCCTGTGGCA-
AGTCAATAG-39 and its reverse complement and for BS2, 59-
Figure 8. Effect of the state of activation of the Ras/MAPK signalling cascade on the regulation of slou by Ara/Caup in LT and VA
lineages. In the wild-type LT3–4 promuscular cluster, where Ras/MAPK signalling is inactive, Caup represses slou since in embryos mutant for ara/
caup (Df(3L)iroEGP6), the absence of Caup allows slou activation in this cluster and the consequent transformation of LT3–4 muscles to VA1–2 muscles.
In the wild-type Caup is absent from the DER-dependent VA1–2 cluster that expresses slou. Ectopic expression of Caup in the VA1–2 lineages using
Con-GAL4 (active after founder segregation when MAPK signalling is extinguished) represses slou in VA2. On the contrary, Con-GAL4 driven expression
of Caup together with the activated form of Ras alleviates Caup-dependent slou repression in the VA2 muscle.
doi:10.1371/journal.pgen.1002186.g008
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CCATATACATATGTGTGCATGTATGCATAAGTGTGAG-
TGTGAGTGGG -39 and its reverse complement. pAC5.1-Caup-
HA plasmid was obtained after cloning caup ORF with an HA tag
in the Drosophila expression vector pAC5.1 (Invitrogen). Drosophila
S2 cells were cultured in Insect-Xpress medium (Lonza)
supplemented with 7% fetal bovine serum and grown at 25uC.
For Luciferase assays S2 cells were seeded at a density of 26106
and co-transfected with 1 mg of the different firefly Luciferase
reporter constructs DNA, 30 ng of control plasmid (expressing
Renilla Luciferase driven by the promoter of Drosophila
RpIII128, [64]) and either 0, 0.25, 0.5 or 1 mg of pAC5.1-
Caupolican-HA plasmid per well using Nucleofector Technology
(Lonza). Luciferase activity in the cell extracts was measured using
Dual-Glo Luciferase assay system (Promega) following the
manufacturer’s protocol. Briefly, 20 ml extract was added to
100 ml F-luc assay reagent, mixed gently for 5 s and placed in a
luminometer. After counting F-luc activity for 10 s, 100 ml stop-
and-glo reagent was added to the tube, mixed gently for 5 s and
placed in the luminometer for R-luc count. The R-luc activities
were used as internal control to correct for the difference in
transfection efficiency of different reporter plasmids. Therefore, F-
Luc/R-Luc activities were used for data analysis. To investigate
whether the MEK/ERK pathway was involved in transcriptional
regulation driven by the slou promoter, S2 cells were treated or not
with 50 mM PD-98059 (Sigma) for 2 hrs before Luciferase activity
measurement. All data reported are means from three or four
independent experiments, each performed in triplicates. Primary
antibodies used in immunoblots were mouse anti-dpErk (1 mg/ml;
Sigma), rat anti-HA (200 ng/ml; Roche) and mouse anti-btubu-
line (1:5000; Developmental Studies Hybridoma Bank).
Generation of slou reporter transgenic lines
The 59-upstream region of slou used in S2 cells in the Luciferase
reporter assays (both the wild type sequence and that missing the
putative Caup BS1) were subcloned at the EcoRI site of the
C4PLZ enhancer tester plasmid that contains a weak P-element
promoter [65]. These lacZ reporter plasmids were introduced into
y w1118 embryos by standard P-element transformation.
Electrophoretic mobility shift assay
Caup binding ability to the slou promoter region was analyzed
by EMSA. Pairs of single-stranded, Cyc3 and unlabeled 40-mer
oligonucleotides containing the wild-type putative Caup binding
sites BS1, BS2 and their mutant or deleted versions were allowed
to anneal to generate double-stranded probes. Sequences of
primers are shown in Figure 6D for BS1 and in Dataset S1. Caup
protein was synthesized in vitro by using the coupled transcription/
translation rabbit reticulocyte lysate system (TNT Promega). The
indicated amount of ml of TNT reaction mixture was incubated
with 20 ng of labelled probe. Protein–DNA complexes were
allowed to form at room temperature for 30 min in a total volume
of 20 ml of binding buffer (50 mM HEPES, pH 7.5, 10 mM
MgCl2, 10 mM KCl and 1 mM DTT). After incubation, free
DNA and protein–DNA complexes were resolved by 6% non-
denaturing polyacrylamide gel electrophoresis. Gel fluorescence
was analyzed in a Typhoon Scanner (GE healthcare).
Supporting Information
Dataset S1 Sequences of primers used in EMSA to analyse
binding of Caup to BS2. Pairs of 40-mer oligonucleotides
containing the wild-type putative Caup binding sites BS2 and
their mutant or deleted versions are shown.
(DOCX)
Figure S1 Pattern of expression of muscle marker genes in
Df(3L)iroDFM3 embryos. (A–D) RNA in situ hybridisation with lms
probes of stage 13 (A, B) and stage 15 (C, D) yw (A, C) and
Df(3L)iroDFM3 (B, D) embryos, showing the normal early onset of
lms expression in the lateral region of abdominal segments in the
mutant embryos (B, compare to A) and its absence of expression at
later stages (D, compare to C). (E, F) Lateral view of stage 14 yw (E)
and Df(3L)iroDFM3 (F) embryos stained with anti-Con antibodies,
showing the absence of Con-expressing lateral muscles (asterisk in
F) and the presence of Con-expressing DT1, VA2 and ectopic VA2
(VA2* in F) in Df(3L)iroDFM3 embryos (F, compare to E). (G, H)
Lateral view of stage 15 yw (G) and Df(3L)iroDFM3 (H) embryos
stained with anti-Lb antibodies to show the presence of lb-
expressing SMB in Df(3L)iroDFM3 embryos (H, compare to G).
(TIF)
Figure S2 Regulation of caup expression during embryogenesis.
(A, B) Lateral view of stage 15 wild-type (A) and Df(2L)5 (B)
embryos stained with anti-Alien (green) and anti-Caup (red). Note
that in Df(2L)5 embryos despite the absence of Caup ectodermal
expression (asterisk in A), apodema specification (labelled by Alien)
and Caup mesodermal expression (arrowheads) are indistinguish-
able from wild-type embryos.
(TIF)
Figure S3 Caup BS1 but not BS2 of slou cis-regulatory region is
evolutionary conserved between Drosophila species in the melano-
gaster group. The slou cis-regulatory region used in this study was
compared between drosophilids using the VISTA Browser tool of
VISTA tools for comparative genomics (http://genome.lbl.gov/
vista/index.shtml). We found a high degree of similarity in this
region between D. melanogaster and other members of the
melanogaster subgroup (D. simulans, D. yakuba and D. erecta) and
only partial similarity with more distant species like D. ananassae
(melanogaster group) and D. pseudoobscura (obscura group). BS1 is
located in a highly conserved region and its sequence is identical
across the melanogaster group, whereas BS2 is located in a region
of low conservation and not found in any of the related species.
Significant similarities on slou coding and cis regulatory regions
were only found between Drosophila melanogaster and the closer
drosophilid species D. simulans, D. yakuba, D. erecta and D.
ananassae. No homology was found using the BLAST tool
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) with Anopheles gambie,
Apis mellifera, Xenopus tropicalis, Danio rerio, Mus musculus and Homo
sapiens.
(TIF)
Figure S4 Deletion of Caup BS1 promotes lac-Z expression in
LT muscles driven by slou cis-regulatory region. Lateral views of
stage 15 slou-lacZ (A, A9) and DBS1-slou-lacZ (B, B9) embryos
stained with anti-Caup (green), anti-ßgal (red) and anti-Myo (blue)
antibodies. Note absence of lacZ expression in LT muscles of slou-
lacZ embryos (arrows in A, A9) and co-expression of caup and lacZ
in LT muscles of DBS1-slou-lacZ embryos (arrows in B, B9).
(TIF)
Figure S5 Repression of slou by ectopic expression of Ara.
Lateral views of stage 15 wild-type (A) and mef2-GAL4::UAS-ara
(B-B9) embryos stained with anti- Tropomyosin (red) and anti-
slou (green) antibodies. (A) Note slou expression in DT1, VA2 and
VT1 muscles (arrows). (B) Early expression of ara with the
panmesodermal driver mef2-GAL4 represses slou in DT1, VA2
and VT1 in many segments (arrows). A few muscles maintain slou
expression (asterisks).
(TIF)
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